Developing tools to study immune responses to COVID-19 and other infectious diseases
COVID supplement: Tetramer Research & Development
['FUNDING_OTHER'] · EMORY UNIVERSITY · NIH-10678174
This study is all about making better tools that help scientists learn how our immune system fights infections like COVID-19, so they can create better vaccines and treatments faster.
Quick facts
| Phase | ['FUNDING_OTHER'] |
|---|---|
| Study type | Nih_funding |
| Sex | All |
| Sponsor | EMORY UNIVERSITY (nih funded) |
| Locations | 1 site (ATLANTA, UNITED STATES) |
| Trial ID | NIH-10678174 on ClinicalTrials.gov |
What this research studies
This research focuses on enhancing the production and distribution of specialized reagents that help scientists study how the immune system responds to infections, including COVID-19. By improving these reagents, researchers can better understand how T cells recognize and respond to pathogens, which is crucial for developing effective vaccines and treatments. The project aims to make these tools more sensitive and quicker to produce, thereby accelerating research in immunology and infectious diseases.
Who could benefit from this research
Good fit: Ideal candidates for participation or benefit from this research include individuals affected by infectious diseases, particularly those with immune system challenges.
Not a fit: Patients with non-infectious diseases or those not affected by immune system disorders may not receive direct benefits from this research.
Why it matters
Potential benefit: If successful, this research could lead to improved understanding and treatment of infectious diseases, potentially enhancing vaccine development and patient outcomes.
How similar studies have performed: Previous research has shown success in using similar reagents to study immune responses, indicating a strong potential for this approach.
Where this research is happening
ATLANTA, UNITED STATES
- EMORY UNIVERSITY — ATLANTA, UNITED STATES (ACTIVE)
Researchers
- Principal investigator: ALTMAN, JOHN — EMORY UNIVERSITY
- Study coordinator: ALTMAN, JOHN
About this research
- This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
- Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
- For full project details, budget, and progress reports, visit the official NIH RePORTER page below.
Conditions: Communicable Diseases, Infectious Disease Pathway, Infectious Diseases, Infectious Disorder, Disease